Any current/future capex/capital investment/strategic investment?

No big capex planned for the next 1-2 years in Agrochemical or other segments. Focus is on optimizing existing capacities and improving profitability rather than new capital investments. Multipurpose plant (investment ~INR 400 crore) started 1.5 years ago with expected revenue ramp-up over 2-3 years to INR 1,000 crore. Small modifications planned in Titanium Dioxide plant to increase capacity post antidumping duty. Nano urea business growth will come without high capex; focus on market development and approvals. Overall, the management intends to deleverage and reduce debt without major fresh

Future growth expectations in sales/revenue/volumes?

Agrochemical segment expected to grow ~20% in next financial year with sustained demand and improved margins (~14-16% EBITDA margin). Multipurpose plant (INR 400 crore investment) to generate over INR 1,000 crore revenue in 2-3 years with gradual ramp-up and better utilization. Pigment segment revenue stable between INR 550-650 crore yearly; margins gradually improving but no significant growth expected. Titanium Dioxide (TiO2) segment revenue estimated at INR 250-300 crore at current capacity; potential to increase post antidumping duty enforcement expected by March 2025. Nano Urea an

Future growth expectations in earnings/operating earnings/profits/EPS?

**Revenue Growth**: Expecting about 20% growth in the Agrochemical segment in FY26. The multipurpose plant is projected to generate over INR 1,000 crore in revenue within 2-3 years. **Margins**: Agrochemical segment margins expected in the range of 14%-16% EBITDA in near term. Pigment segment margins projected to improve gradually. **Pigment Segment**: Revenue range stable at INR 550-650 crore yearly; no major growth expected beyond this. **Titanium Dioxide (TiO2)**: Current revenue potential INR 250-300 crore with existing capacity, with significant increase possible post implementation of

Meghmani Organics LtdQ3 FY25Fertilizers & Agrochemicals

Meghmani Organics Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹59.55P/E: 23.6Market Cap: ₹1.5K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Order

N/A

Capex

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

Agrochemical segment expected to grow ~20% in next financial year with sustained demand and improved margins (~14-16% EBITDA margin).
Multipurpose plant (INR 400 crore investment) to generate over INR 1,000 crore revenue in 2-3 years with gradual ramp-up and better utilization.
Pigment segment revenue stable between INR 550-650 crore yearly; margins gradually improving but no significant growth expected.
Titanium Dioxide (TiO2) segment revenue estimated at INR 250-300 crore at current capacity; potential to increase post antidumping duty enforcement expected by March 2025.
Nano Urea and Crop Nutrition products show strong growth potential but require time to build farmer acceptance; a large opportunity given urea market size.
Overall, core segments (crop protection and pigment) regaining growth momentum and aiming to resume double-digit growth.
Focus remains on Agrochemical segment as core growth driver with new products and geographic expansion.

Margin guidance

Category 1

Revenue Growth: Expecting about 20% growth in the Agrochemical segment in FY26. The multipurpose plant is projected to generate over INR 1,000 crore in revenue within 2-3 years.
Margins: Agrochemical segment margins expected in the range of 14%-16% EBITDA in near term. Pigment segment margins projected to improve gradually.
Pigment Segment: Revenue range stable at INR 550-650 crore yearly; no major growth expected beyond this.
Titanium Dioxide (TiO2): Current revenue potential INR 250-300 crore with existing capacity, with significant increase possible post implementation of antidumping duty (expected around March 2025).
Debt Reduction: Target to be debt-free by FY27 on a standalone basis, supporting profitability.
Overall Profitability: Earnings and EBITDA have shown marked improvement; expect continued improvement as market conditions normalize and capacity ramps up.

See what Meghmani Organics Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- Meghmani Organics Limited does not plan any big capital expenditure (capex) for the next 1-2 years in Agrochemical or other segments, indicating no major new fund requirement. - The company aims to reduce its current debt from INR 474 crore (consolidated long-term debt) and expects to be debt free by FY26-27. - No explicit mention of new equity fundraising was made in the transcript. - Focus remains on deleveraging through operations rather than raising fresh capital. Overall, the management's approach is to avoid fresh debt or equity fundraising in the near term and focus on debt reduction and organic growth.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Meghmani Organics Limited. However, relevant insights related to business outlook and capacity utilization include: - Crop Protection segment utilization stood at about 78%, with production increasing 12% to ~10,700 metric tons in Q3 FY25. - Expected revenue growth of about 20% in Agrochemical segment for the next financial year. - Multipurpose plant has the potential to generate INR 1,000 crore revenue in 2-3 years. - Titanium Dioxide segment revenue potential with current capacity is INR 250-300 crore, with prospects to increase post antidumping duty implementation. - Pigment segment revenue expected between INR 550-650 crore with some margin improvement, but no significant growth beyond this. - Growth outlook is positive, with incremental capacity and antidumping duty expected to aid ramp-up and order fulfillment. No direct numeric details on pending orders or order book were disclosed in the call.

See what Meghmani Organics Ltd management said on order book — free account, 30 seconds.

Capex plans

No big capex planned for the next 1-2 years in Agrochemical or other segments.
Focus is on optimizing existing capacities and improving profitability rather than new capital investments.
Multipurpose plant (investment ~INR 400 crore) started 1.5 years ago with expected revenue ramp-up over 2-3 years to INR 1,000 crore.
Small modifications planned in Titanium Dioxide plant to increase capacity post antidumping duty.
Nano urea business growth will come without high capex; focus on market development and approvals.
Overall, the management intends to deleverage and reduce debt without major fresh capex.

Track Meghmani Organics Ltd — get its next earnings analysis in your feed

How does Meghmani Organics Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisMeghmani Organics Ltd

Rev 2Mar 1

See where Meghmani Organics Ltd sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Meghmani Organics Ltd rank in Fertilizers & Agrochemicals?

Compare Meghmani Organics Ltd against every Fertilizers & Agrochemicals company (Q3 FY25) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What Meghmani Organics Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Bhagiradha Chemicals & Industries Ltd (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
Bhagiradha Chemicals & Industries Ltd (Q3 FY26)
114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran
Advance Agrolife Ltd (Q3 FY26)
Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways
Dhansa Labs Ltd (Q4 FY26)
120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs Sumitomo Chemical India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →